Page URL:

E-CRISPR could be used to rapidly detect viruses

18 November 2019
Appeared in BioNews 1024

Researchers claim that CRISPR could be used to detect dangerous viruses in a drop of blood within an hour.

The team at Case Western Reserve University in Cleveland, Ohio, harnessed CRISPR's precision to identify and quantify viruses in human samples, including serum from blood. Their technique, named E-CRISPR, could offer a robust, accurate and cost-effective way to enable faster diagnoses of infections such as parvovirus which can cause miscarriages and human papillomavirus (HPV) which is associated with some cancers. 

'This could someday become a simple, accurate and cost-effective point-of-care device for identifying different nucleic acid viruses, such as HPV or parvo from a single droplet of a blood sample,' said first author Yifan Dai, a PhD candidate at Case Western. 'And it would also be extremely fast.'

HPV and parvovirus are both DNA viruses, and their genomic material will be present in the blood of an infected person. E-CRISPR uses a CRISPR RNA strand to bind target sequences which are unique to the virus, and when attached, the associated Cas12a (also known as Cpf1) enzyme cuts the viral DNA in the same way as it would in CRISPR/Cas9 genome editing.

However, unlike Cas9, Cas12a is known to indiscriminately cut single-stranded DNA (ssDNA) once activated by the double-stranded target – in this case the viral sequence. The researchers used ssDNA strands, tethered at one end to a sensor and with an electrochemical tag molecule at the other to detect if this cut has been made. If Cas12a is activated, these ssDNA strands are cut, detaching the tag molecules and the electrochemical current detectable through the sensor drops, giving an observable result.

'The CRISPR technique works so that it cuts all of the non-specified single-strand DNA around it once the target is recognised, so we program to electrochemically probe this activity,' said Dai. 'No virus – no cutting, it's that simple. And the opposite is true: If CRISPR starts to cut, we know the virus is present.'

The researchers hope that this method could be further developed to create a new 'universal biosensing' device able to accurately detect viruses quickly at the point-of-care, similar to existing blood-glucose sensors. Currently, systems that detect HPV and parvovirus take days to process.

The study was published in Angewandte Chemie, a journal of the German Chemical Society.

13 January 2020 - by Bernie Owusu-Yaw 
Promising results from clinical trials give hope for using CRISPR genome editing to treat various heritable diseases and cancer in humans...
16 September 2019 - by Charlotte Spicer 
Chinese scientists have used the genome editing tool CRISPR in an attempt to treat HIV in a patient with blood cancer, for the first time...
5 November 2018 - by Dr Eleanor Lynam 
The genome editing system, CRISPR/Cas9, may not be as successful in humans as hoped...
6 August 2018 - by Dr Alexander Ware 
The key enzyme used in CRISPR genome editing has competition...
29 May 2018 - by Shaoni Bhattacharya 
Scientists in Japan have harnessed genome editing to successfully block the HIV virus from replicating inside infected cells....
19 February 2018 - by Rikita Patel 
Researchers have found a new use for CRISPR, adapting the system to detect viral infections with high accuracy, a new study finds...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.